Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

News

Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
Elasmogen Secure £8M Funding Round

24th May 2022

Elasmogen, which is part of the Deepbridge Life Sciences EIS fund, recently secured £8 million in their latest funding round. This investment should…

Full article
Hurricane Commerce & AEB Sign Strategic Partnership

23rd May 2022

One of Deepbridge Capital's Technology Growth EIS Companies, Hurricane Modular Commerce Limited, has recently agreed a strategic partnership with AEB…

Full article
SmallSpark Awarded Funding By Research England

18th May 2022

SmallSpark Space Systems, an award-winning rocket propulsion innovation company which is part of the Deepbridge Technology Growth EIS fund, has been…

Full article
Aegiq Closes Seed Funding Round

16th May 2022

Aegiq, a University of Sheffield spin-out developing networking technology that's secure in the quantum computing age, has closed a Seed funding…

Full article
School Wellbeing Accelerator Wins Award

12th May 2022

School Wellbeing Accelerator, an investee company within the Deepbridge Life Sciences EIS portfolio, has won the ‘Best Wellbeing Solution’ at the…

Full article
Compono Appoints New CEO

11th May 2022

Compono, an investee company within the Deepbridge Technology Growth EIS portfolio, has appointed Trent Innes, former Managing Director of Xero…

Full article
Touch Biometrix Announces Successful Series B Funding Round

29th April 2022

Touch Biometrix, an investee company within the Deepbridge Technology Growth EIS portfolio, has announced a successful Series B funding round, with…

Full article
Deepbridge Reports Record Year of Funding

25th April 2022

As of the 25th April 2022, Deepbridge Capital is proud to announce that it has deployed a record £31.5 million into early-stage technology and life…

Full article
Sky Medical Technology's geko™ Device Available Across India's Government Hospitals

19th April 2022

Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced the availability of its flagship…

Full article
Filisia Selected for 'Play For All Accelerator'

17th April 2022

Filisia, an investee company within the Deepbridge Life Sciences EIS portfolio, has been selected to participate in the 'Play For All Accelerator' by…

Full article
Sky Medical Technology Wins Further FDA Clearance

14th April 2022

Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced further U.S. Food and Drug…

Full article
Deepbridge Sponsors Snooker Player Louise Burton

8th April 2022

Deepbridge are pleased to announce that we have sponsored Louise Burton, a snooker player who is currently ranked 39th in the world by World Women's…

Full article